These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 1655299)

  • 21. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block.
    Naguib M; Abdulatif M
    Anesth Analg; 1994 Feb; 78(2):306-11. PubMed ID: 8311284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium.
    Dubois MY; Fleming NW; Lea DE
    Anesth Analg; 1991 Mar; 72(3):364-8. PubMed ID: 1847278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dose-response evaluation of pipecuronium bromide in elderly patients under balanced anesthesia.
    Azad SS; Larijani GE; Goldberg ME; Beach CA; Marr AT; Seltzer JL
    J Clin Pharmacol; 1989 Jul; 29(7):657-9. PubMed ID: 2547848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Edrophonium antagonism of vecuronium at varying degrees of fourth twitch recovery.
    Salib YM; Donati F; Bevan DR
    Can J Anaesth; 1993 Sep; 40(9):839-43. PubMed ID: 8104729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
    Marcotte J; Drolet P; Perreault L; Girard M
    Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between pipecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1987 Nov; 43(3):308-12. PubMed ID: 2832912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Edrophonium antagonism of pancuronium-induced neuromuscular blockade in man: a reappraisal.
    Kopman AF
    Anesthesiology; 1979 Aug; 51(2):139-42. PubMed ID: 453615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide.
    Wierda JM; Szenohradszky J; De Wit AP; Zentai G; Agoston S; Kakas M; Kleef UW; Meijer DK
    Eur J Anaesthesiol; 1991 Nov; 8(6):451-7. PubMed ID: 1662599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the neuromuscular blocking effect of Arduan.
    Tassonyi E
    Ther Hung; 1983; 31(1):13-7. PubMed ID: 6100820
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block.
    Morita T; Kurosaki D; Tsukagoshi H; Sugaya T; Saito S; Sato H; Fujita T
    Can J Anaesth; 1996 Aug; 43(8):799-805. PubMed ID: 8840059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
    Ripart J; Drolet P; Perreault L; Girard M
    Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intravenous hypnotics on the actions of pipecuronium.
    Dutre P; Rolly G; Vermeulen H
    Eur J Anaesthesiol; 1992 Jul; 9(4):313-7. PubMed ID: 1321037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different priming techniques, including mivacurium, accelerate the onset of rocuronium.
    Naguib M
    Can J Anaesth; 1994 Oct; 41(10):902-7. PubMed ID: 8001208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability of pipecuronium neuromuscular blockade.
    Diefenbach C; Mellinghoff H; Buzello W
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):189-91. PubMed ID: 8383402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
    Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
    Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.